Keke Chen - Dept Pediat Hematol & Oncol, Hunan Normal Univ

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 34 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

A Type of Brain-Targeting Nano-Formulation and Its Anti-Tumour Effect in Paediatric Brain Tumour Cells

Xin Tian, Taoxiang Shi, Shiyang Fu, Zheda Liu,Yalan You,Keke Chen,Anqi Yao,Chengguang Zhu,Minhui Zeng,Wenfang Tang,Xiaojun Tao,Xiangling He

Materials technologyno. 1 (2024)

引用0浏览0引用

HAND2-AS1 Plays a Tumor-Suppressive Role in Hepatoblastoma Through the Negative Regulation of CDK1

Keke Chen,Yalan You, Wenfang Tang, Xin Tian,Chengguang Zhu,Zexi Yin,Minhui Zeng,Xiangling He

HELIYONno. 17 (2024)

引用0浏览0WOS引用

RT-PCR Demonstrates Superior Sensitivity and Specificity in Detecting the Five Neuroblastoma Genes Compared to the Flow Cytometry Method for Measurable Residual Disease

Xin Tian, Hanpeng Li, Tong Luo,Junqing Mao,Xiaojun Yuan, Qun Gao,Jianwen Xiao,Shuqin Qian,Runying Zou,Keke Chen,Chengguang Zhu,Canhong Yi,Xiangling He

Translational Pediatricsno. 12 (2023): 2232-2246

引用0浏览0WOS引用

造血干细胞移植术后儿童感染新型冠状病毒Omicron的临床特征分析

吴帅,曾敏慧, 贺晶, 田鑫,陈可可,贺湘玲

Journal of Hunan Normal University(Medical Science)no. 3 (2023)

引用0浏览0引用

Clinical Characteristics and Prognosis Analysis of Patients with De Novo ASXL1 ‐mutated AML Treated with the C‐HUNAN‐AML‐15 Protocol: A Multicenter Study by the South China Pediatric AML Collaborative Group

Minhui Zeng,Keke Chen,Xin Tian,Runying Zou,Xiaoqin Feng,Chunfu Li,Jian Li,Mincui Zheng,Huirong Mai,Lihua Yang,Yingyi He,Honggui Xu,Hong Wen,Xiangling He

Cancer medicineno. 12 (2023): 13182-13192

引用0浏览0WOS引用

Immunoregulatory Effects of Human Amniotic Mesenchymal Stem Cells and Their Exosomes on Human Peripheral Blood Mononuclear Cells

Xin Tian,Xiangling He,Shuqin Qian,Runying Zou,Keke Chen,Chengguang Zhu,Zexi Yin

Biocell（2023）

引用0浏览0引用

间充质细胞联合利妥昔单抗治疗造血干细胞移植后血小板减少1例

贺晶,贺湘玲,陈可可,邹润英,朱呈光,田鑫

Journal of China Pediatric Blood and Cancerno. 2 (2023)

引用0浏览0引用

Allogeneic Hematopoietic Stem Cell Transplantation Corrects Ligase IV Deficiency

Jing He, Xin Tian, Tong Luo,Runying Zou,Zexi Yin,Keke Chen,Chengguang Zhu,Xiangling He

Transplant immunology (2023): 101897-101897

引用0浏览0WOS引用

A Multicenter Phase II Trial of Primary Prophylactic PEG‐rhG‐CSF in Pediatric Patients with Solid Tumors and Non‐hodgkin Lymphoma after Chemotherapy: an Interim Analysis

Junting Huang,Suying Lu,Juan Wang,Lian Jiang,Xuequn Luo,Xiangling He,Yanpeng Wu,Yi Wang,Xiuli Zhu,Jian Chen,Yanlai Tang,Keke Chen, Xin Tian,Boyun Shi,Lanying Guo,Jia Zhu,Feifei Sun,Zijun Zhen,Yizhuo Zhang

CANCER MEDICINEno. 13 (2023): 14130-14137

引用1浏览0WOS引用

The Properties of Cholesterol-Modified Pullulan Nanoparticles with Different PEG Coatings and Their Anti-Hepatoblastoma Cell Effects

Xin Tian,Xiangling He,Anqi Yao,Yalan You,Fan Yang,Keke Chen,Chengguang Zhu,Minhui Zeng,Qin Shi,Wenfang Tang,Xuelong Fan,Xiaojun Tao

MATERIALS TECHNOLOGY（2022）

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn